WHO ICTRP trial

Comparison of the efficacy of 131I versus anti-thyroid drugs in the treatment of…

ISRCTN10856337 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting

Key facts

Trial ID ISRCTN10856337
Public title Comparison of the efficacy of 131I versus anti-thyroid drugs in the treatment of hyperthyroidism
Scientific title A 9-year Prospective, Randomized, Open-label, Blinded End point (PROBE) treatment study to compare the efficacy of 131I versus anti-thyroid drugs in the treatment of hyperthyroidism
Primary sponsor Sun Yat-sen University (China)
Registry International Standard Randomised Controlled Trial Number (ISRCTN)
Recruitment status Not Recruiting
Study type Interventional
Phase Not Specified
Countries China
Conditions Hyperthyroidism Nutritional, Metabolic, Endocrine Hyperthyroidism
Interventions Recruitment took place in the province of Guangdong, China. Participants were randomised to the intervention and control groups in equal numbers. Intervention group: Participants received one application of 131I (oral), followed by a second…
Registration date Dec 21, 2007
Target size 460
Secondary IDs 1.0
Registry page isrctn.com

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations